Cíl: Studovat tuhost cévní stěny pacientů s ischemickou chorobou srdeční na základě prevalence aterosklerotických změn. Materiál a metody: Do studie bylo zařazeno 90 pacientů s diagnózou nestabilní anginy pectoris třídy II B, kontrolní skupinu tvořilo 27 zdravých osob. Ukazatele tuhosti tepen jako rychlost pulsní vlny (pulse wave velocity, PWV) a index augmentace (augmentation index, AIx) byly hodnoceny metodou aplanační tonometrie s použitím přístroje SphygmoCor (AtCor Medical, Austrálie). Koronarografi cké vyšetření se provádělo přístrojem Allura CV-20 (Philips, Nizozemsko); stav karotid se posuzoval duplexní sonografi í a postižení femorálních tepen se hodnotilo pomocí indexu kotník-paže < 0,9. V případě pochybností absolvoval pacient duplexní ultrazvukové vyšetření. Pacienti v hlavní skupině byli dále rozděleni do tří podskupin: podskupinu A tvořili pacienti s izolovanou koronární lézí; do podskupiny B byli zařazeni pacienti s bifokální ateroskleró-zou (kombinace změn na koronárních a karotických tepnách, nebo na koronárních a femorálních tepnách); podskupinu C zastupovali pacienti s multifokální aterosklerózou, která byla prokázána v třech cévních řečištích: karotickém, koronárním a femorálním. Výsledky: Hodnoty PWV (11,2 ± 1,5 m/s) a AIx (19,8 ± 5,0 %) u pacientů s ischemickou chorobou srdeční byly 1,5× (p < 0,001), resp. 2,4× (p < 0,001) vyšší než u zdravých osob. Při analýze údajů jednotlivých podskupin bylo zaznamenáno zrychlení PWV ve všech třech podskupinách, přičemž maximálních hodnot bylo dosaženo v podskupině C (13,3 ± 1,5 m/s), což dostatečně spolehlivě překračuje hodnoty tohoto parametru v podskupině A (10,1 ± 0,6; p < 0,01) i B (11,0 ± 0,9; p < 0,05). I hodnota AIx byla byla vyšší v podskupině C (26,8 ± 6,4 %) než v podskupinách A (13,7 ± 2,9 %; p < 0,001) a B (18,9 ± 4,3 %; p < 0,01). Závěr: U pacientů s ischemickou chorobou srdeční byla prokázána zvýšená tuhost cévních stěn projevující se vyšší rychlostí pulsové vlny (p < 0,001) a vyšším augmentačním indexem (p < 0,001) ve srovnání se zdravými jedinci, zatímco u pacientů s multifokální aterosklerózou (koronární, karotické a periferní tepny) byly nalezeny vyšší hodnoty AA (p < 0,05), AIx (p < 0,001), PWV (p < 0,01) a vyšší věk pacienta (p < 0,01). Na základě tohoto zjištění lze hodnocené parametry tuhosti cév považovat za zástupné (náhradní) markery při hodnocení prevalence a progrese aterosklerózy i účinnosti farmakologických intervencí.
Introduction
In recent years, scientifi c studies have revealed strong evidence for the role of increased stiffness of vascular wall in progression of hypertension and development of its major complications. For example, a correlation between increased vascular wall stiffness (measured based on the pulse wave velocity, PWV) and mortality rate was established in patients with hypertension in the REASON study [1] . The ASCOT-CAFE large-scale study [2] showed that the effect of antihypertensive therapy on the prognosis of patients with hypertension for a comparable decrease in brachial blood pressure (BP) depends on the degree of central aortic pressure reduction, which is modulated by elastic properties of large arteries.
According to the Framingham's criteria, PWV can be even stronger predictor of fatal and nonfatal cardiovascular complications than smoking, blood glucose, total cholesterol and other biological markers [3] . For the fi rst time, in European (2007) and Russian (2008) recommendations on diagnosis and treatment of hypertension, vascular wall was identifi ed as a "target organ" of the hypertensive process and increased PWV was included in the list of criteria for subclinical target organ damage in patients with hypertension. This indicator remained in the revised European recommendations on diagnosis and treatment of hypertension adopted in 2013 [4] , where the carotid-femoral PWV was identifi ed as an indicator infl uencing the prognosis of patients with hypertension.
However, the value of the vascular wall stiffness index in patients with coronary heart disease (CHD), depending on the severity of the disease and the intensity of atherosclerosis is the least studied topic.
Objective: to study stiffness of vascular wall in patients with CHD depending on the prevalence of atherosclerotic lesion.
Material and methods
The main group included 90 patients (54 men and 36 women) aged between 42 and 71 received by the coronary artery disease department of the Republican Specialized Center for Cardiology in 2015 with unstable angina (progressive angina II B class). The CHD diagnosis was confi rmed by the results of veloergometry and coronary angiography (CAG). In addition, the study included 27 volunteers (15 men and 12 women) with the excluded cardiovascular disease, who were presented as a control group. The patients of the main group were divided into 3 subgroups: subgroup A included patients with isolated coronary artery disease; subgroup B -patients with bifocal atherosclerosis: a combined lesion in the coronary and carotid arteries, or coronary and femoral arteries; subgroup C represented patients with multifocal atherosclerotic process in which damage was detected in the three basins of the cardiovascular system (CVS): carotid, coronary and femoral arteries.
The vascular wall stiffness was studied based on the examination of the central systolic blood pressure (cSBP), central diastolic blood pressure (cDBP), central pulse pressure (cPP), aortic augmentation (AA), augmentation index (AIx), pulse wave velocity (PWV) by using the Netherlands) unit, the state of the carotid arteries was studied by duplex ultrasonography, involvement of femoral arteries was evaluated based on ankle-brachial index < 0.9. In case of doubt, the patients underwent ultrasound duplex scanning. In the main group, patients were divided into 3 subgroups: subgroup A covered patients with isolated coronary lesion; subgroup B covered patients with bifocal atherosclerosis (combined lesion of coronary and carotid arteries or coronary and femoral arteries); subgroup C was represented by multifocal atherosclerosis patients who had atherosclerosis lesion in three vascular basins: carotid, coronary and femoral arteries. Results: Values of PWV (11.2 ± 1.5 m/s) and AIx (19.8 ± 5.0%) in patients with coronary heart disease were 1.5 (p < 0.001) and 2.4 (p < 0.001) times higher than in those in healthy individuals. During the analysis carried out within the groups, the PWV in all three subgroups was accelerated with maximal values in the subgroup C (13.3 ± 1.5 m/s), which with sufficient level of confidence exceeds the value of this index in the subgroups A (10.1 ± 0.6, p < 0.01) and B (11.0 ± 0.9, p < 0.05). The value of AIx was also highest in the subgroup C (26.8 ± 6.4%), relative to the subgroups A (13.7 ± 2.9%, p < 0.001) and B (18.9 ± 4.3%, p < 0.01).
Conclusion:
Patients with coronary heart disease, have demonstrated growing vascular wall stiffness, which is manifested in higher pulse wave velocity (p < 0.001) and augmentation index (p < 0.001) compared with healthy individuals. Whereas in the multifocal atherosclerosis (coronary, carotid and peripheral arteries) were higher AA (p < 0.05), AIx (p < 0.001), PWV (p < 0.01) and the age of patients (p < 0.01). That allows to consider the studied parameters of vascular stiffness as surrogate markers to assess prevalence and progression of atherosclerosis, as well as the effectiveness of pharmacological interventions.
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Coronary and multifocal atherosclerosis Coronary heart disease Pulse wave velocity applanation tonometry and by means of the SphygmoCor equipment (AtCor Medical, Australia). Applanation tonometry was performed on a patient in the lying position after a 10-minute rest. The patient's passport data, anthropometric data, SBP and DBP measured manually by tonometry were entered into the computer software. The sensor of applanation tonometer was mounted on a radial artery and pulse wave was recorded to obtain high-quality recording with a minimal duration of 10 s, followed by automatic calculations to determine the parameters of central hemodynamics. In order to estimate the PWV, the distance (expressed in mm) from the pulse of the femoral artery to the clavicle (distal distance) and the distance (expressed in mm) from the pulse of the carotid artery to the clavicle (proximal distance) was measured. Consequently, three ECG electrodes were applied on the upper limbs and the left foot, pulse wave was consistently recorded at the carotid and femoral arteries with simultaneous ECG recording, and the PWVs were automatically calculated.
Ultrasonography of the carotid arteries was performed by means of the ALOKA -Multi View (Japan) ultrasound systems equipped with 7 MHz linear sensor (20 m) and SONOLINE VERSA PRO (SIEMENS, Germany). Images of the common carotid arteries (CCA) were obtained from the both sides in real time in synchronization with the R-wave of the ECG. During the sonography of the carotid arteries, thickness of the intima-media (IMT) posterior wall of the distal one-third of the CCA on both sides was estimated with the calculation of the maximal thickness of the IMT for 10-mm part proximal to the bifurcation, and size of atherosclerosis plaque with determination of stenosis percentage (%) by the diameter of the CCA.
Coronary angiography was performed on the Allura CV-20 (Philips, the Netherlands) unit. In order to assess the degree of arterial stenosis, the following characteristics, like: normal coronary artery, abnormal artery contouring without determining the degree of stenosis, stenosis of < 50%, stenosis of 51-75%, 76-95%, 95-99% (subtotal) and 100% (occlusion) were visually examined. Hemodynamically signifi cant (> 50%) and non-signifi cant coronary artery stenosis <50% cases were considered to be atherosclerotic lesions.
Femoral arteries involvement was evaluated based on the ankle-brachial index (ABI) of less than 0.9. In case of doubt, patients underwent ultrasound duplex scanning. According to recommendations of the European Society of Cardiology, ABI surpasses other methods such as history taking, questioning and checking pulse on peripheral arteries by palpation. The sensitivity and specifi city of this indicator applied for peripheral arterial diseases detection reach up to 95% when the signifi cant stenosis of the lower limbs arteries is angiographically verifi ed [5] .
The distribution of patients by clinical and demographic data is presented in Table. 1 Data obtained in this study was analyzed by using the methods of parametric and non-parametric variation statistics including calculations of the arithmetic mean values of the studied indicator (M), standard errors of the mean ( ), and the relative values (frequency, %). To compare the mean values, the statistical signifi cance of the measurements was determined by the t-test (Student's t--distribution) with calculation of the error probability (p). For statistically signifi cant changes the confi dence level of p <0.05 was used.
Results of the study
Based on the results of the test, the structure of the main group was as follows: subgroup A -28 patients (31.1%), subgroup B -45 patients (50%), subgroup C -17 (18.9%).
All the patients were prescribed basic treatment, which included dual antiplatelet therapy (aspirin 75 mg and clopidogrel 75 mg), beta-blockers (bisoprolol) 2.5-10 mg/ day, ACE inhibitors (perindopril, if the target blood pressure is not achieved), and statins (atorvastatin) ( Table 2) .
As can be seen from the table 2 in patients with multifocal atherosclerosis (subgroup C) were signifi cantly higher the total cholesterol (p < 0.05), the triglycerides (p < 0.01), the cholesterol of low-density lipoproteins (LDL--C) (p < 0.05) and lower the cholesterol of high-density lipoproteins (HDL-C) (p < 0.05) than in the subgroup A.
Indicators of applanation tonometry were studied in each subgroup separately and the values were compared Table 2 -Comparative characteristics of baseline lipid, carbohydrate metabolism, and initial treatment in the studied groups of patients with coronary heart disease.
Indicators
Main group (n = 90) Subgroup A (n = 28) Subgroup B (n = 45) Subgroup C (n = 17) both within the subgroups and with the control group. Data is presented in Tables 3 and 4 . According to the applanation tonometry, in general, central hemodynamic parameters in patients with CHD during treatment corresponded to acceptable limits, although the mean values of the cSBP (p <0.05) and CPP (p <0.05) were somewhat higher than those values in healthy individuals, which could be probably explained by the fact that 67 (74.4%) patients had essential hypertension with controlled blood pressure values.
At the same time, in patients of the main group the values of PWV were 1.5 times (11.2 ± 1.5 m/s), and AIx -2.4 times (19.8 ± 5.0 %) higher than those of the control group (p <0.001).
During the analysis carried out within the groups, the PWV in all three subgroups was accelerated with maximal values in the subgroup C (13.3 ± 1.5 m/s), which with suffi cient level of confi dence exceeded the value of this index in the subgroups A (10.1 ± 0.6, p < 0.01) and B (11.0 ± 0.9, p < 0.05). AIx augmentation index value was also highest in the subgroup C (26.8 ± 6.4) relative to subgroups A (13.7 ± 2.9, p < 0.001) and B (18.9 ± 4.3, p < 0 01). PWV, m/s 11.2 ± 1.5*** 7.6 ± 0.7 * < 0.05, ** < 0.01, *** < 0.001 -confi dence level of differences relative to the control group; AA -aortic augmentation; AIx -augmentation index; cDBP -central diastolic blood pressure; cPP -central pulse pressure; cSBP -central systolic blood pressure; PWV -pulse wave velocity.
Discussion
Atherosclerosis is a dynamic process that develops over time determining remodeling of the arterial wall and does not clinically manifest itself, but its development often leads to acute clinical manifestations. Due to the complexity and inconvenience of invasive control methods (angiography, coronary angiography), reliable noninvasive surrogate markers are required to monitor the development and progression of atherosclerosis. These methods include ultrasound scanning of the main arteries to determine the ABI thickness and several indicators of the vascular wall stiffness, like: elasticity coeffi cient, distensibility coeffi cient, Peterson's elastic modulus, stiffness index, Young's modulus [6] . However, it is nowadays known that pulse wave velocity (PWV) evaluation is the «gold» standard for measurement of aortic stiffness. It is known that PWV increases successively as the accumulation of atherosclerosis risk factors: hypertension [7] , dyslipidemia [8] , impaired glucose tolerance [9] , and diabetes [10] . Carotid atherosclerosis becomes the next early and obvious link of this sequence [11] . Finally, in a sufficiently large number of longitudinal studies reported on the correlation PWV with cardiovascular and cerebrovascular complications of atherosclerosis [12, 13] .
Rotterdam study, for the fi rst time, demonstrated a high correlation between increasing of pulse wave velocity (a marker of arterial stiffness) and presence of atherosclerosis, whereas the data obtained in that study made it possible to study this parameter as a predictor of prognosis for patients with CHD [14] . Independent studies based on angiography demonstrated that vascular wall stiffness increases proportionally to the number of atherosclerosis-impaired coronary arteries [15, 16] . The results obtained in our study also confi rm the correlation of the atherosclerosis prevalence with an increase of pulse wave velocity and augmentation index. The fact that patients with atherosclerotic vascular lesions of the three regions the average age was higher than in the subgroups with coronary atherosclerosis and bifocal, once again confi rms its simultaneous impact on both the aging of blood vessels, and the prevalence of atherosclerosis [17] . AIx, % 13.7 ± 2.9 18.9 ± 4.3 26.8 ± 6.4*** PWV, m/s 10.1 ± 0.6 11.0 ± 0.9 13.3 ± 1.5** * p < 0.05, ** p < 0.01, *** p < 0.001 -confi dence level of differences between subgroup C with the subgroup A; p < 0.05, p < 0.01 -confi dence level of differences between subgroup B with the subgroup C; AA -aortic augmentation; AIx -augmentation index; cDBPcentral diastolic blood pressure; cPP -central pulse pressure; cSBP -central systolic blood pressure; PWV -pulse wave velocity.
Conclusion
Patients with coronary heart disease, have demonstrated growing vascular wall stiffness, which is manifested in higher pulse wave velocity (p < 0,001) and augmentation index (p < 0,001) compared with healthy individuals. Thus, in patients with vascular lesions of the two vascular beds (the coronary arteries and carotid) AIx (p < 0.01) and PWV (p < 0.05) were higher than in isolated coronary lesions. Whereas in the multifocal atherosclerosis (coronary, carotid and peripheral arteries) were higher AA (p < 0.05), AIx (p < 0.001), PWV (p < 0.01) and the age of patients (p < 0.01). That allows to consider the studied parameters of vascular stiffness as surrogate markers to assess prevalence and progression of atherosclerosis, as well as the effectiveness of pharmacological interventions.
